P < .001), favored OST therapy. Conclusions: With equal success rates between hemodialysis access thrombectomy methods, RT has the lowest operating and total cost, whereas OST has significantly better profit margins in a hospital-based setting. All thrombectomy procedure types had a negative profit margin in an outpatient hospital-based setting. PERC using RT decreases operative time, blood loss, and cost compared with PMT. Combination percutaneous thrombectomy leads to the greatest financial loss compared with any single therapy. With recent reimbursement/bundling changes for percutaneous hemodialysis thrombectomy, OST should be considered first-line treatment for occluded hemodialysis access in a hospitalbased setting, whereas RT may be more cost-efficient in office-based settings as the cost profile is more favorable. Background: Patients with multiple failed dialysis accesses and limited access sites can present a significant challenge to vascular surgeons. The presence of central venous occlusion and the need for temporary or permanent dialysis catheter placement are especially problematic. Previous reports have described an "inside-out" technique that avoids the need for subclavian or femoral catheter placement by placing a supraclavicular catheter through a percutaneous femoral vein. However, very few reports of its use in vascular surgery exist. The purpose of this paper was to describe our version of the technique and to report the results.
Background: Patients with multiple failed dialysis accesses and limited access sites can present a significant challenge to vascular surgeons. The presence of central venous occlusion and the need for temporary or permanent dialysis catheter placement are especially problematic. Previous reports have described an "inside-out" technique that avoids the need for subclavian or femoral catheter placement by placing a supraclavicular catheter through a percutaneous femoral vein. However, very few reports of its use in vascular surgery exist. The purpose of this paper was to describe our version of the technique and to report the results.
Methods: All procedures were performed using general anesthesia or conscious sedation supplemented with local anesthesia. Ultrasound guidance was used for common femoral venous access, and a superior venacavogram, anteroposterior and oblique views, was obtained to document the level of caval occlusion. An 8F, 81-cm-long, braided trans-septal sheath (Swartz Braided SL1; St. Jude Medical, St. Paul, Minn) was advanced until the tip of the dilator was at the level of the caval occlusion. The tip was then oriented anterolaterally toward the clavicular head. After this, the back end of a 0.014-inch Confianza wire (Asahi Intecc, Aichi, Japan) was passed through the dilator, forced through the vein wall (achieving a subcutaneous location), and advanced until it tented the skin at the base of the neck posterior to the clavicle. Next, a small incision was made over the wire before it was grasped with a hemostat and retrieved from the subcutaneous tissue. A micropuncture sheath was then placed over the back end of the Confianza wire and advanced into the SL1 catheter. After injection of contrast material to confirm placement, a 0.035-inch Amplatz Super Stiff guidewire (Boston Scientific, Marlborough, Mass) was advanced through the microsheath into the SL1 catheter. The guidewire was then advanced into the inferior vena cava while the SL1 catheter was withdrawn. The tunneled catheter was placed in standard fashion.
Results: Between August 2016 and July 2017, eight patients underwent dialysis catheter placement by this technique (Table) . All patients had more than four prior access sites and had bilateral internal jugular vein occlusion. Technical success rate was 100%, with no periprocedural complications. All procedures were successful in achieving a functioning dialysis access. One patient required catheter replacement within 48 hours secondary to inadequate tip placement proximal to the right atrium. One catheter was used as a bridge to HeRO graft (Merit Medical, South Jordan, Utah) placement. One patient died of sepsis unrelated to the catheter.
Conclusions: Our data show the inside-out catheter placement technique to be safe and effective. This procedure allows avoidance of subclavian or femoral catheter placement and should be a component of every vascular surgeon's treatment algorithm for complex dialysis patients. Background: Placement of large transfemoral sheaths through the iliac system during fenestrated endovascular aneurysm repair (FEVAR) leads to lower extremity (LE) ischemia that is associated with serious neurologic complications. We sought to determine the effect of the continuous LE ischemia time (cLEIT) on neurologic impairment after FEVAR.
Methods: Consecutive patients who underwent FEVAR at a single institution were analyzed. The cLEIT was calculated from the time of insertion of a large sheath (at least 18F) to the time of sheath removal from the iliac arteries that led to continuous LE ischemia. Common iliac artery (CIA) lumen was defined as diameter of the truly patent lumen of a CIA. Neurologic impairment was defined as any new sensory or motor deficit in either LE. Outcomes were summarized with descriptive statistics and modeled with logistic regression with interaction terms. Individual LE was used as the unit of analysis.
Results: We examined 101 patients (202 extremities) who underwent FEVAR during a 5-year period. The median cLEIT was 2.75 hours (range, 1.3-5.2 hours). Neurologic impairment developed in 18 (9%) of the extremities. Among those 18 affected extremities, 12 (67%) developed mild sensory loss, 8 (13%) complete sensory loss, 4 (22%) loss of proprioception, and 2 (11%) motor dysfunction; sensory deficit was permanent in 4 (2%) and motor dysfunction in 1 (0.5%) of the total extremities assessed. In all other cases, neurologic status returned to normal by postoperative day 15 (median recovery, 4 days; range, 1-14 days). One patient (both LEs) underwent fasciotomy postoperatively. There were no amputations. Duration of cLEIT (odds ratio, 21.6; 95% confidence interval, 8-57.6; P < .001) and CIA lumen of 8 mm or less (odds ratio, 5.7; 95% confidence 
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